MOLLY WIWI: Open Payments
NPI 1922519669 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,802 in 113 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $1,004 · 2025 $1,802
Food & beverage: $1,802
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 38 | $250 |
| Abbott Laboratories | 4 | $181 |
| Xeris Pharmaceuticals, Inc. | 10 | $136 |
| RECORDATI_RARE_DISEASES_INC. | 5 | $120 |
| Ascendis Pharma Endocrinology Inc | 4 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $108 |
| Dexcom, Inc. | 4 | $106 |
| Lilly USA, LLC | 5 | $84 |
| Amgen Inc. | 4 | $77 |
| Chiesi USA, Inc. | 3 | $75 |
Products named: Omnipod, FREESTYLE LIBRE 3, ISTURISA, Yorvipath, Kerendia, Dexcom G6 Transmitter, MOUNJARO, GVOKE HYPOPEN.
Industry payments across KS — which companies pay providers there.
